GMT.WA
Price:
$4.4
Market Cap:
$66.28M
Genomtec S.A. researches, develops, manufactures, and commercializes innovative molecular diagnostic products in optical systems and isothermal nucleic acid amplification methods in Poland and internationally. The company develops Genomtec ID, a technological device that offer mobile genetic diagnosis to patients through streamlined nucleic acid amplification technology (SNAAT) to detect viruses, bacteria, and fungi, as well as genetic mutations by analyzing the biological material of patients using swabs, urine samples, saliva, blood, and other body fluids. It also develops Genomtec Tumor, a SNAAT based solution used to identify neoplastic mutations and mutations with prognostic value in ne...[Read more]
Industry
Medical - Devices
IPO Date
2021-03-17
Stock Exchange
WSE
Ticker
GMT.WA
According to Genomtec S.A.’s latest financial reports and current stock price. The company's current PE Ratio is -5.30. This represents a change of -47.79% compared to the average of -10.15 of the last 4 quarters.
The mean historical PE Ratio of Genomtec S.A. over the last ten years is -21.73. The current -5.30 PE Ratio has changed 2.34% with respect to the historical average. Over the past ten years (40 quarters), GMT.WA's PE Ratio was at its highest in in the December 2022 quarter at -4.13. The PE Ratio was at its lowest in in the June 2021 quarter at -27.43.
Average
-21.73
Median
-10.41
Minimum
-76.41
Maximum
-9.12
Discovering the peaks and valleys of Genomtec S.A. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 60.73%
Maximum Annual PE Ratio = -9.12
Minimum Annual Increase = -86.77%
Minimum Annual PE Ratio = -76.41
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | -9.36 | -36.18% |
| 2023 | -14.66 | 60.73% |
| 2022 | -9.12 | -14.91% |
| 2021 | -10.72 | 6.09% |
| 2020 | -10.11 | -86.77% |
The current PE Ratio of Genomtec S.A. (GMT.WA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-11.05
5-year avg
-10.79
10-year avg
-21.73
Genomtec S.A.’s PE Ratio is less than Medinice S.A. (2.63), greater than NanoGroup S.A. (-12.86), less than Pure Biologics Spólka Akcyjna (-1.35), less than BioMaxima S.A. (68.99), less than Airway Medix S.A. (19.28), less than Poltreg S.A. (-4.57), less than Adiuvo Investments S.A. (6.32), greater than Urteste S.A. (-12.44), less than Molecure S.A. (-4.97), greater than Pharmena S.A. (-17.12),
| Company | PE Ratio | Market cap |
|---|---|---|
| 2.63 | $99.27M | |
| -12.86 | $90.06M | |
| -1.35 | $33.30M | |
| 68.99 | $48.43M | |
| 19.28 | $36.35M | |
| -4.57 | $111.46M | |
| 6.32 | $8.56M | |
| -12.44 | $51.73M | |
| -4.97 | $150.20M | |
| -17.12 | $33.97M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Genomtec S.A. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Genomtec S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Genomtec S.A.'s PE Ratio?
How is the PE Ratio calculated for Genomtec S.A. (GMT.WA)?
What is the highest PE Ratio for Genomtec S.A. (GMT.WA)?
What is the 3-year average PE Ratio for Genomtec S.A. (GMT.WA)?
What is the 5-year average PE Ratio for Genomtec S.A. (GMT.WA)?
How does the current PE Ratio for Genomtec S.A. (GMT.WA) compare to its historical average?